-
Product Insights
NewQuarterly Iced/RTD Coffee Drinks pricing trends in the United States
Empower your strategies with our Quarterly Iced/RTD Coffee Drinks pricing trends in the United States report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and...
-
Product Insights
NewYpsomed Holding AG Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Ypsomed Holding AG Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, therapy management, monitoring services, and IP landscape management to manufacturing...
-
Product Insights
NewQuarterly Hot Coffee pricing trends in the United States
Empower your strategies with our Quarterly Hot Coffee pricing trends in the United States report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
IP Athos Solar PV Park
IP Athos Solar PV Park is a solar PV project located in California, United States. The project is owned by Terras Energy Corp and is developed by Intersect Power Inc; SB Energy Holdings LLC. The project is currently partially active. Empower your strategies with our IP Athos Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
IP Titan Solar PV Park
IP Titan Solar PV Park is a solar PV project located in Texas, United States. The project is owned by SB Energy Holdings LLC and was developed by Intersect Power Inc; SB Energy Holdings LLC. The project came online in 2021. Empower your strategies with our IP Titan Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
IP Fukushima Onocho Solar PV Park
IP Fukushima Onocho Solar PV Park is a solar PV project located in Fukushima, Japan. The project is owned and developed by Integrity Patners LLC. The project came online in 2019. Empower your strategies with our IP Fukushima Onocho Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DSP-1083 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DSP-1083 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DSP-1083 in Parkinson's Disease Drug Details: DSP-1083 is under development for the...
-
Sector Analysis
NewInternet from Sky – Can LEO Satellites Transform the Future of Connectivity? (Vol. 2)
LEO Satellites - Internet from Sky Report Overview The surge in low earth orbit (LEO) satellite projects indicates a global trend toward diversifying internet coverage. This trend focuses on bridging the digital divide and enhancing real-time data transmission for various sectors, including aerospace and defense. LEOs provide a competitive edge due to their lower latency, and their increasing deployment signifies a pivotal shift toward a more connected future. LEOs are more secure than terrestrial networks as communication happens in space...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-010 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-010 in Metastatic Ovarian Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-010 in Metastatic Ovarian Cancer Drug Details: PEP-010 (DPTC-9h) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEP-010 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEP-010 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEP-010 in Pancreatic Ductal Adenocarcinoma Drug Details: PEP-010 (DPTC-9h) is under...